March 30, 2021 – The March/April 2021 edition of Retina Specialist magazine includes a feature article emphasizing the readiness of artificial intelligence (AI) for use in screening for diabetic retinopathy (DR). In the article “AI in retina: Ready for prime time?” the EyeArt® system’s outstanding real-world results in detection of more than mild and vision-threatening DR are highlighted:
“The [EyeArt] system performed remarkably well, with the company reporting a sensitivity of 96 percent and specificity of 88 percent in detecting referable DR, and sensitivity of 92 percent and specificity of 94 percent for detecting vision threatening DR. Real-world trials of the technology have found similar accuracy.”
Click here to read the full article.